Cogent Biosciences Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 15 | Q3 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | 33.3 | 50.3 | 38.2 | 13.5 | 12.5 | 6.6 | 3.9 | 1.0 | 0.5 | 0.6 | 3.9 | 14.9 | 365.4 | 998.0 | – | – | – | – | – | – | – | – | – | 91.6 | 113.7 | 149.2 | 212.9 | 200.7 | 159.2 | 191.1 | 469.1 | – | – | – | |
| – | – | – | – | – | – | 18.4 | 5.5 | 4.6 | 2.2 | 2.7 | 2.0 | 1.5 | 0.7 | 0.5 | 0.7 | 0.8 | 0.5 | 1.4 | 1.5 | 1.7 | 1.8 | 1.8 | 1.4 | 3.6 | 3.2 | 3.4 | 2.5 | 2.8 | 2.0 | 1.5 | 2.2 | 3.8 | 3.4 | 3.1 | 5.3 | 6.7 | 9.0 | 10.8 | 12.4 | |
| – | – | – | – | – | – | – | – | – | 8.2 | 7.1 | 2.1 | -0.1 | -0.6 | -0.6 | -0.2 | -1.6 | -15.6 | 93.2 | 306.0 | – | – | – | – | – | – | – | – | – | 82.3 | 75.3 | 133.7 | 195.8 | 178.2 | 130.2 | 172.0 | 450.6 | – | – | – | |
| – | – | – | – | – | – | -9.3% | -7.0% | -10.0% | -25.4% | -27.9% | -50.4% | -98.9% | -188.2% | -306.6% | -243.6% | -38.6% | -30.6% | -12.8% | -14.0% | -14.5% | -16.1% | -23.0% | -20.9% | -11.1% | -15.3% | -18.0% | -16.2% | -17.0% | -30.6% | -26.5% | -21.3% | -16.1% | -24.2% | -32.6% | -28.6% | -12.3% | -4.7% | -4.4% | -4.7% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | 32.1% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -8.9% | -83.8% | -194.7% | -90.3% | -54.1% | -48.0% | -29.5% | -227.0% | -1,835.4% | -3,471.2% | – | – | – | – | – | – | – | – | – | 35.8% | 29.7% | 32.1% | 27.8% | -25.6% | -27.2% | -29.0% | – | – | – | – | |
| – | – | – | – | -54.1% | -312.8% | -309.3% | -365.4% | -420.8% | -369.9% | -386.7% | -348.6% | -394.2% | -143.0% | -100.0% | -97.8% | -295.8% | -1,044.3% | -10,578.3% | -31,649.7% | – | – | – | – | – | – | – | – | – | -3,724.6% | -4,067.6% | -4,377.2% | -4,660.6% | -6,429.1% | -6,721.1% | -6,981.9% | -7,166.9% | – | – | – | |
| – | – | – | – | -48.9% | -304.9% | -300.3% | -353.1% | -405.1% | -354.8% | -373.7% | -340.4% | -387.9% | -141.5% | -99.1% | -96.8% | -264.1% | -950.4% | -9,576.4% | -28,717.3% | – | – | – | – | – | – | – | – | – | -3,443.3% | -3,796.9% | -4,063.1% | -4,336.0% | -5,961.3% | -6,279.1% | -6,618.7% | -6,858.6% | – | – | – | |
| – | – | – | – | – | -319.9% | -310.9% | -354.2% | -380.5% | -343.1% | -349.2% | -331.8% | -385.5% | -184.7% | -143.1% | -146.1% | -150.9% | -455.5% | -4,681.3% | -13,984.9% | – | – | – | – | – | – | – | – | – | -2,799.2% | -3,013.6% | -3,184.1% | -3,437.7% | -4,854.7% | -5,191.6% | -5,467.1% | -5,748.7% | – | – | – | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | -82.8% | -90.1% | -165.4% | -38.4% | -48.3% | -57.3% | -80.1% | -103.1% | -149.3% | -100.2% | -102.1% | -120.1% | -52.7% | -31.9% | -35.5% | -42.1% | -29.8% | -33.7% | -48.5% | -34.3% | -43.3% | -54.8% | -66.3% | -45.2% | -58.7% | -74.6% | -50.2% | -60.8% | -77.0% | -99.8% | -123.1% | -183.2% | -97.3% | -51.7% | -58.3% | -70.8% | |
| – | – | – | – | -50.6% | -51.9% | -60.6% | -28.7% | -34.4% | -40.2% | -48.6% | -59.1% | -73.8% | -64.4% | -67.4% | -74.4% | -43.7% | -29.8% | -33.9% | -39.2% | -27.3% | -31.1% | -44.1% | -29.9% | -37.9% | -46.6% | -56.3% | -40.1% | -50.0% | -61.4% | -44.6% | -52.8% | -63.1% | -78.0% | -95.0% | -103.4% | -69.1% | -35.1% | -39.2% | -45.2% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| – | -8.1 | – | – | – | -25 | – | – | – | -52 | -58 | -54 | -44 | -36 | -28 | -20 | -127 | -240 | -229 | -216 | -201 | -217 | -189 | -317 | -139 | -138 | -160 | -213 | -85 | -52 | -214 | -87 | -96 | -97 | -124 | -82 | -79 | -88 | -17 | 44 | |
| – | 71.5% | – | – | 61.1% | 57.6% | 36.6% | 74.6% | 71.2% | 70.1% | 60.6% | 57.4% | 49.4% | 64.3% | 66.0% | 62.0% | 83.0% | 93.5% | 95.4% | 93.1% | 91.6% | 92.3% | 90.8% | 87.3% | 87.4% | 85.0% | 84.9% | 88.8% | 85.2% | 82.3% | 88.7% | 86.8% | 81.9% | 78.2% | 77.2% | 56.4% | 71.0% | 67.9% | 67.3% | 63.8% | |
| – | 0.0 | – | – | – | 0.1 | – | – | – | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.2 | 0.4 | 0.4 | 0.4 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | -3.86 | -4.35 | -4.00 | -4.04 | -4.37 | -4.62 | -5.25 | -5.37 | -5.58 | -4.15 | -3.48 | -2.97 | -6.21 | -7.15 | -2.31 | -2.33 | -1.47 | -1.65 | -2.02 | -2.22 | -1.80 | -1.99 | -2.10 | -2.10 | -2.06 | -2.22 | -2.24 | -2.29 | -2.20 | -2.32 | -2.37 | -2.49 | -2.11 | -2.04 | -2.07 | -2.21 | |
| – | – | – | – | 7.90 | 1.43 | 1.33 | 1.14 | 1.08 | 1.30 | 1.41 | 1.58 | 1.44 | 2.93 | 3.51 | 3.07 | 2.35 | 0.75 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.06 | 0.06 | 0.05 | 0.04 | 0.04 | 0.04 | 0.03 | 0.00 | 0.00 | 0.00 | |
| – | 17.56 | – | – | 4.66 | 4.83 | 2.42 | 10.52 | 9.04 | 8.06 | 6.55 | 5.21 | 3.73 | 4.14 | 3.41 | 2.47 | 11.78 | 22.42 | 6.50 | 5.54 | 4.95 | 4.89 | 4.16 | 6.47 | 4.17 | 3.63 | 3.16 | 4.66 | 3.52 | 2.97 | 4.45 | 3.76 | 2.86 | 2.32 | 1.92 | 1.36 | 2.16 | 3.95 | 3.56 | 3.11 | |
| – | – | – | – | – | -4.57 | -4.14 | -4.05 | -4.10 | -4.47 | -4.91 | -5.24 | -5.54 | -5.42 | -5.03 | -4.48 | -3.55 | -3.43 | -1.13 | -1.14 | -1.22 | -1.38 | -1.73 | -1.88 | -1.66 | -1.78 | -1.94 | -1.91 | -1.66 | -1.80 | -1.78 | -1.79 | -1.74 | -1.89 | -1.96 | -2.06 | -1.76 | -1.65 | -1.68 | -1.81 | |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.